3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia.
Hrib
N J
NJ
Department of Chemical Research, Hoechst-Roussel Pharmaceuticals, Inc., Somerville, New Jersey 08876.
Jurcak
J G
JG
Bregna
D E
DE
Dunn
R W
RW
Geyer
H M
HM
Hartman
H B
HB
Roehr
J E
JE
Rogers
K L
KL
Rush
D K
DK
Szczepanik
A M
AM
D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D000818:Animals; D014150:Antipsychotic Agents / Q000378:metabolism / Q000627:therapeutic use*; D051379:Mice; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D011985:Receptors, Serotonin / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy*; D013379:Substrate Specificity; D013764:Tetrahydronaphthalenes / Q000494:pharmacology; D013844:Thiazoles / Q000378:metabolism / Q000627:therapeutic use*; D053778:Thiazolidines
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin; D013764:Tetrahydronaphthalenes; D013844:Thiazoles; D053778:Thiazolidines; C075804:HP 236; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin